FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness​FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness 

 The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.  ​​The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.